Covid-19 vaccines, what just happened at the FDA, and why it matters

This is not how vaccine policy should be made.

Yesterday, the FDA Commissioner, Marty Makary, and his new advisor, Vinay Prasad, unveiled a major shift in U.S. Covid-19 vaccine policy—via a New England Journal of Medicine perspective piece and a live FDA event.

Their bottom line: Going forward, Covid-19 vaccines will only be recommended for people over 65 or with at least one chronic condition. If ma…